Filing Flows › Staar Surgical (STAA) › Q3 2026 › vs Q2 2026
Staar Surgical (STAA) Q3 2026 vs Q2 2026 (quarter over quarter)
Staar Surgical's revenue fell $10.1M (-11%) from $93.5M in Q2 2026 to $83.4M in Q3 2026. Gross margin 70.9% against 74.5% (-3.7 pts).
Staar Surgical, Q3 2026: revenue $83.4M (-12% year over year), operating margin 6.5%, net earnings $5.6M, operating cash flow $27.3M. The chart draws each line against Q2 2026, the increases inside each band.
Margins
| Q3 2026 | Q2 2026 | Change | |
|---|---|---|---|
| Gross margin | 70.9% | 74.5% | -3.7 pts |
| Operating margin | 6.5% | 10.8% | -4.3 pts |
| Net margin | 6.7% | 8.6% | -1.9 pts |
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $83.4M | $93.5M | −$10.1M | -11% |
| Gross profit | $59.1M | $69.7M | −$10.6M | -15% |
| Cost of revenue | $24.3M | $23.8M | $468K | +2% |
| Other income, net | $1.5M | $923K | $598K | +65% |
| Operating profit | $5.5M | $10.1M | −$4.6M | -46% |
| Operating expenses | $53.7M | $59.6M | −$6.0M | -10% |
| Pre-tax earnings | $7.0M | $11.0M | −$4.0M | -37% |
| Net earnings | $5.6M | $8.1M | −$2.5M | -31% |
| Income tax | $1.4M | $3.0M | −$1.6M | -53% |
| Depreciation | $2.4M | $2.4M | $44K | +2% |
| Share-based compensation | $5.5M | $6.6M | −$1.0M | -16% |
| Working capital & other | $13.8M | $2.7M | $11.1M | +414% |
| Operating cash flow | $27.3M | $19.7M | $7.6M | +39% |
Questions
How much did Staar Surgical's revenue grow quarter over quarter in Q3 2026?
Staar Surgical's revenue fell $10.1M (-11%) from $93.5M in Q2 2026 to $83.4M in Q3 2026. Gross margin 70.9% against 74.5% (-3.7 pts).